Compugen (CGEN) Net Cash Flow (2009 - 2010)
Compugen's (CGEN) quarterly Net Cash Flow came in at $3.0 million in Q4 2010, down 68.11% year-on-year from $9.5 million in Q4 2009, and up 139.57% quarter-over-quarter from -$7.6 million in Q3 2010.
Compugen (CGEN) Net Cash Flow (2009 - 2010) Analysis & Trends
Compugen has disclosed Net Cash Flow across 2 years of filings, most recently posting $3.0 million for Q4 2010.
- Net Cash Flow for Q4 2010 came in at $3.0 million, down 68.11% year-over-year; the trailing twelve-month figure through Sep 2011 was $3.0 million (up 64.35% YoY), and the FY2025 annual result was $72.2 million, up 1749.28% from the prior year.
- Net Cash Flow came in at $3.0 million for Q4 2010 at Compugen, up from -$7.6 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $9.5 million in Q4 2009 to a low of -$7.6 million in Q3 2010.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 625.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 457.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 664,983.53 |
| 10 | Compugen | 189.59 Mn | 97.83 Mn | 352,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2010 | 3.02 Mn |
| Dec 31, 2010 | 3.02 Mn |
| Sep 30, 2010 | -7.64 Mn |
| Sep 30, 2010 | -7.64 Mn |
| Dec 31, 2009 | 9.48 Mn |
| Dec 31, 2009 | 9.48 Mn |
| Sep 30, 2009 | -935,000.00 |
| Sep 30, 2009 | -935,000.00 |